000 | 01995 a2200565 4500 | ||
---|---|---|---|
005 | 20250517183015.0 | ||
264 | 0 | _c20171229 | |
008 | 201712s 0 0 eng d | ||
022 | _a1520-4804 | ||
024 | 7 |
_a10.1021/acs.jmedchem.7b01304 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBueno, Ana B | |
245 | 0 | 0 |
_aOptimization of Hydroxyethylamine Transition State Isosteres as Aspartic Protease Inhibitors by Exploiting Conformational Preferences. _h[electronic resource] |
260 |
_bJournal of medicinal chemistry _c12 2017 |
||
300 |
_a9807-9820 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAmyloid Precursor Protein Secretases _xantagonists & inhibitors |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAspartic Acid Endopeptidases _xantagonists & inhibitors |
650 | 0 | 4 |
_aBrain _xmetabolism |
650 | 0 | 4 | _aCrystallography, X-Ray |
650 | 0 | 4 | _aCyclization |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 |
_aEthylamines _xchemistry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aModels, Molecular |
650 | 0 | 4 |
_aMorpholines _xchemistry |
650 | 0 | 4 |
_aPeptides _xchemistry |
650 | 0 | 4 |
_aProtease Inhibitors _xchemistry |
650 | 0 | 4 | _aStructure-Activity Relationship |
700 | 1 | _aAgejas, Javier | |
700 | 1 | _aBroughton, Howard | |
700 | 1 | _aDally, Robert | |
700 | 1 | _aDurham, Timothy B | |
700 | 1 | _aEspinosa, Juan Félix | |
700 | 1 | _aGonzález, Rosario | |
700 | 1 | _aHahn, Patric J | |
700 | 1 | _aMarcos, Alicia | |
700 | 1 | _aRodríguez, Ramón | |
700 | 1 | _aSanz, Gema | |
700 | 1 | _aSoriano, José F | |
700 | 1 | _aTimm, David | |
700 | 1 | _aVidal, Paloma | |
700 | 1 | _aYang, Hsiu-Chiung | |
700 | 1 | _aMcCarthy, James R | |
773 | 0 |
_tJournal of medicinal chemistry _gvol. 60 _gno. 23 _gp. 9807-9820 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/acs.jmedchem.7b01304 _zAvailable from publisher's website |
999 |
_c27739843 _d27739843 |